altRX vs Trinity Meds

altRX has an open FDA warning letter dated June 8, 2026. Trinity Meds has none. On compounded semaglutide injection, altRX costs $120 less a year at standing rates: $89 a month against $99 a month at Trinity Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Trinity Meds

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Trinity Meds logo

Trinity Meds

9.3/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
Lowest standing price
$89/moCompounded semaglutide injection
$99/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Trinity Meds pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Trinity Meds 9.3). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Trinity Meds has none.

  2. 02

    altRX names four pharmacies. Trinity Meds names four pharmacies.

  3. 03

    On compounded semaglutide injection, altRX costs $120 less a year at standing rates: $89 a month against $99 a month at Trinity Meds.

  4. 04

    Only altRX lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Trinity Meds

Compounded semaglutide injection

$89/moLower

$1,068 a year

$99/mo

$1,188 a year

Compounded tirzepatide injection

$149/mo

$1,788 a year

$149/mo

$1,788 a year

Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
None on the monthly plan; multi-month plans are prepaid and non-refundable
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
All payments are final and non-refundable, except a partial refund if you are medically disqualified

Read off each seller’s own pages. altRX: September 28, 2026. Trinity Meds: October 25, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • $120 a year less on compounded semaglutide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Trinity Meds does not price
  • Open FDA warning letter, June 8, 2026

The case for Trinity Meds

9.3/10
  • No FDA warning letter on record

Scores

altRX 8.8 · Trinity Meds 9.3 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
9.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Trinity Meds: questions

altRX has an open FDA warning letter dated June 8, 2026. Trinity Meds has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Trinity Meds names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
altRX, by $120 a year at standing rates. altRX: $89 a month, about $1,068 a year. Trinity Meds: $99 a month, about $1,188 a year.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Trinity Meds states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Trinity Meds pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Trinity Meds 9.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks